Ozempic Shows Potential for Alcohol Addiction in Trial

By News Health
1 month Ago

(MedPage Today) — Weekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving in adults with alcohol use disorder (AUD), a phase II randomized trial showed.
At 9 weeks, semaglutide…

Source link : https://www.medpagetoday.com/psychiatry/addictions/114191

Author :

Publish date : 2025-02-12 18:44:07

Copyright for syndicated content belongs to the linked Source.

Categories: Health News

Related Content

Transplant Doc's Future in U.S. Uncertain Following Her Deportation to Lebanon

This Vaccine Researcher Was Caught in the NIH Funding Cut Crossfire

Experts Sound the Alarm on Pricey Skin Substitutes in Wound Care Industry

Daily Oral Islatravir and Doravirine Just as Effective as Other ART Regimens for HIV

Supranormal EF; Cannabis Use and CVD; Cardiologist's Sex Crime Accusations

Future of Canadian Guidelines, Task Force in Doubt